Trends in Left Ventricular Assist Device Utilization and Survival Outcomes Following the Donor Allocation Policy Change
Artificial Organs · 2026
DOI: 10.1111/aor.70046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2026. Verfasst von Christopher D Pritting und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Transplantation, Heart Failure, Tissue and Organ Procurement. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
We sought to estimate left ventricular assist device use (LVAD) with waitlist and post‐transplant survival trends in patients supported on durable LVAD in relation to the UNOS donor heart allocation policy revision.
Methods
Adult patients implanted with HeartMate II LVAD, HeartWare HVAD, or HeartMate 3 LVAD, and listed for isolated heart transplantation between October 18, 2013, and June 16, 2023, were identified in the UNOS database and were stratified into pre‐ and post‐policy revision groups. Patients on temporary circulatory support, right, or biventricular assist devices, total artificial hearts, recipients of donation after circulatory death (DCD) hearts, and those undergoing simultaneous multiorgan transplants were excluded. Waitlist and post‐transplant survival were compared between the groups.
Results
Policy revision was associated with a decrease in LVAD use both at the time of listing (pre: 28% vs. post: 24.5%, p < 0.01) and at the time of transplant (pre: 45.8% vs. post: 31.7%, p < 0.01). For those listed with an LVAD, more patients eventually underwent transplantation (pre: 89.6% vs. post: 94.3%, p < 0.01) following the policy change. Overall waitlist and post‐transplant survival among patients supported on LVAD worsened following the policy change, both showing statistical significance ( p < 0.01).
Conclusion
In the post‐policy era, a decline in durable LVAD utilization was observed, along with worse waitlist and post‐transplant outcomes among LVAD‐supported patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Department of Surgery, Bayhealth Medical Center, Dover, Delaware, USA.
- Division of Cardiac Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia, USA.
- Division of Cardiology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Daler Rahimov, Matthew P Weber
Zitieren
APA
Pritting, C. D., Rahimov, D., Weber, M. P., Storozynsky, E., Eisen, H. J., Rame, J. E., Alvarez, R. J., Rajagopal, K., Entwistle, J. W., & Tchantchaleishvili, V. (2026). Trends in Left Ventricular Assist Device Utilization and Survival Outcomes Following the Donor Allocation Policy Change. Artificial Organs. https://doi.org/10.1111/aor.70046
Vancouver
Pritting CD, Rahimov D, Weber MP, Storozynsky E, Eisen HJ, Rame JE, et al. Trends in Left Ventricular Assist Device Utilization and Survival Outcomes Following the Donor Allocation Policy Change. Artificial Organs. 2026. doi:10.1111/aor.70046
BibTeX
@article{Pritting2026,
author = {Pritting, Christopher D and Rahimov, Daler and Weber, Matthew P and Storozynsky, Eugene and Eisen, Howard J and Rame, J Eduardo and Alvarez, Rene J and Rajagopal, Keshava and Entwistle, John W and Tchantchaleishvili, Vakhtang},
title = {Trends in Left Ventricular Assist Device Utilization and Survival Outcomes Following the Donor Allocation Policy Change},
journal = {Artificial Organs},
year = {2026},
doi = {10.1111/aor.70046}
}
EUVIMED